Northrop Grumman said full-year 2024 sales increased 4% to $41.0 billion, compared with $39.3 billion in 2023, and full-year net earnings were $4.2 billion, or $28.34 per diluted share. Fourth quarter Q4 sales of $10.7 billion were comparable with the prior year period.

1. 01

   Northrop Grumman said full-year 2024 sales increased 4% to $41.0 billion, compared with $39.3 billion in 2023, and full-year net earnings were $4.2 billion, or $28.34 per diluted share. Fourth quarter Q4 sales of $10.7 billion were comparable with the prior year period.

2. 02

   The company said 2024 operating income increased $1.8 billion, or 72%, and operating margin rate rose to 10.6% from 6.5%. It cited the prior year B-21 program charge of $1.56 billion at Aeronautics Systems as the primary driver of the increase.

3. 03

   Northrop Grumman said 2024 operating cash flow was $4.4 billion and free cash flow was $2.6 billion, and it returned $3.7 billion to shareholders through share repurchases and dividends. The company cited improved working capital and higher net earnings as factors in the free cash flow increase.

4. 04

   The company provided 2025 guidance of $42,000 million to $42,500 million in sales, $2,850 million to $3,250 million in free cash flow, and $27.85 to $28.25 in MTM-adjusted EPS. The guidance includes the divestiture of the Training Services business, expected to close mid-year.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.